Cerebral toxoplasmosis in HIV-infected patients: a review

References

• Safarpour H, Cevik M, Zarean M, et al. Global status of Toxoplasma gondii infection and associated risk factors in people living with HIV. AIDS. 2020;34(3):469–474.
   PubMedGoogle Scholar
• CDC. Global health, division of parasitic diseases and malaria. Accessed 1 April 2021. https://www.cdc.gov/parasites/toxoplasmosis/epi.html
   Google Scholar
• Wang ZD, Wang SC, Liu HH, et al. Prevalence and burden of Toxoplasma gondii infection in HIV-infected people: a systematic review and meta-analysis. Lancet HIV. 2017;4(4):e177–e188.
   PubMed Web of Science ®Google Scholar
• WHO. AIDS epidemic update. USAIDS; 2000.
   Google Scholar
• Lakoh S, Jiba DF, Kanu JE, et al. Causes of hospitalization and predictors of HIV-associated mortality at the main referral hospital in Sierra Leone: a prospective study. BMC Public Health. 2019;19(1):1320.
   PubMed Web of Science ®Google Scholar
• Nacher M, Adenis A, Guarmit B, et al. What is AIDS in the Amazon and the Guianas in the 90-90-90 era? PLoS One. 2020;15(7):e0236368.
   PubMed Web of Science ®Google Scholar
• Telles JP, Fernandes R, Barros TD, et al. Neurological manifestations in people living with HIV/AIDS in the late cART era: a prospective observational study at a tertiary healthcare center in São Paulo, Brazil. HIV Res Clin Pract. 2021;22(4): 87–95.
   PubMedGoogle Scholar
• Jianu C, Bolboacă SD, Topan AV, et al. A view of human immunodeficiency virus infections in the North-West Region of Romania. Medicina (B Aires). 2019;55(12):765.
   Google Scholar
• Imran D, Estiasari R, Maharani K, et al. Presentation, etiology, and outcome of brain infections in an Indonesian hospital: a cohort study. Neurol-Clin Pract. 2018;8(5):379–388.
   PubMedGoogle Scholar
• Raberahona M, Razafinambinintsoa T, Andriananja V, et al. Hospitalization of HIV positive patients in a referral tertiary care hospital in Antananarivo Madagascar, 2010–2016: trends, causes and outcome. PLoS One. 2018;13(8):e0203437.
   PubMed Web of Science ®Google Scholar
• El Fane M, Sodqi M, Lamdini H, et al. Central neurological diagnosis in patients infected with HIV in the Infectious Diseases Unit of University Hospital of Casablanca, Morocco. Bull Soc Pathol Exot. 2018;111(1):24–30.
   PubMedGoogle Scholar
• Gams Massi D, Mintyene Mintyene MRR, Magnerou AM, et al. Spectrum of central nervous system infections in a tertiary health care centre in Cameroon. Egypt J Neurol Psychiatr Neurosurg. 2022;58(1):18.
   PubMedGoogle Scholar
• Pacheco PRG, Zara ALSA, Souza SE, et al. Late onset of antiretroviral therapy in adults living with HIV in an urban area in Brazil: prevalence and risk factors. J Trop Med. 2019;2019:5165313.
   PubMed Web of Science ®Google Scholar
• Seo HH, Han HW, Lee SE, et al. Modelling. Emerg Microbes Infect. 2020;9(1):1943–1954.
   PubMed Web of Science ®Google Scholar
• Azovtseva OV, Viktorova EA, Bakulina EG, et al. Cerebral toxoplasmosis in HIV-infected patients over 2015-2018 (a case study of Russia). Epidemiol Infect. 2020;148:e142.
   PubMed Web of Science ®Google Scholar
• Vidal JE. HIV-related cerebral toxoplasmosis revisited: current concepts and controversies of an old disease. J Int Assoc Provid AIDS Care. 2019;18:2325958219867315.
   Google Scholar
• Attias M, Teixeira DE, Benchimol M, et al. The life-cycle of Toxoplasma gondii reviewed using animations. Parasit Vectors. 2020;13(1):588.
   PubMed Web of Science ®Google Scholar
• Elsheikha HM, Marra CM, Zhu XQ. Epidemiology, pathophysiology, diagnosis, and management of cerebral toxoplasmosis. Clin Microbiol Rev. 2021;34(1):e00115–19.
   PubMed Web of Science ®Google Scholar
• Graham AK, Fong C, Naqvi A, et al. Toxoplasmosis of the central nervous system: manifestations vary with immune responses. J Neurol Sci. 2021;420:117223.
   PubMed Web of Science ®Google Scholar
• Corcino YL, Portillo JC, Subauste CS. Epidermal growth factor receptor promotes cerebral and retinal invasion by Toxoplasma gondii. Sci Rep. 2019;9(1):669.
   PubMedGoogle Scholar
• Schlüter D, Barragan A. Advances and challenges in understanding cerebral toxoplasmosis. Front Immunol. 2019;10:242.
   PubMed Web of Science ®Google Scholar
• El Saftawy EA, Shash RY, Aboulhoda BE, et al. Insights into immunopathology and triggering of apoptosis in chronic cerebral toxoplasmosis using murine models. Trop Biomed. 2021;38(2):53–62.
   PubMed Web of Science ®Google Scholar
• Moreira-Souza ACA, Rangel TP, Silva SRBD, et al. Disruption of purinergic receptor P2X7 signaling increases susceptibility to cerebral toxoplasmosis. Am J Pathol. 2019;189(4):730–738.
   PubMed Web of Science ®Google Scholar
• Ihara F, Tanaka S, Fereig RM, et al. Involvement of Toll-like receptor 2 in the cerebral immune response and behavioral changes caused by latent Toxoplasma infection in mice. PLoS One. 2019;14(8):e0220560.
   PubMed Web of Science ®Google Scholar
• Salvioni A, Belloy M, Lebourg A, et al. Robust control of a brain-persisting parasite through MHC I presentation by infected neurons. Cell Rep. 2019;27(11):3254–3268.e8.
   PubMed Web of Science ®Google Scholar
• Suzuki Y. The immune system utilizes two distinct effector mechanisms of T cells depending on two different life cycle stages of a single pathogen, Toxoplasma gondii, to control its cerebral infection. Parasitol Int. 2020;76:102030.
   PubMed Web of Science ®Google Scholar
• Still KM, Batista SJ, O’Brien CA, et al. Astrocytes promote a protective immune response to brain Toxoplasma gondii infection via IL-33-ST2 signaling. PLoS Pathog. 2020;16(10):e1009027.
   PubMed Web of Science ®Google Scholar
• Moreira-Souza ACA, Almeida-da-Silva CLC, Rangel TP, et al. The P2X7 receptor mediates Toxoplasma gondii control in macrophages through canonical NLRP3 inflammasome activation and reactive oxygen species production. Front Immunol. 2017;81257. DOI:10.3389/fimmu.2017.01257
   Web of Science ®Google Scholar
• Alves VS, Leite-Aguiar R, Silva JPD, et al. Purinergic signaling in infectious diseases of the central nervous system. Brain Behav Immun. 2020;89:480–490.
   PubMed Web of Science ®Google Scholar
• Huang SW, Walker C, Pennock J, et al. P2X7 receptor-dependent tuning of gut epithelial responses to infection. Immunol Cell Biol. 2017;95(2):178–188.
   PubMed Web of Science ®Google Scholar
• Corrêa G, Marques da Silva C, de Abreu Moreira-Souza AC, et al. Activation of the P2X(7) receptor triggers the elimination of Toxoplasma gondii tachyzoites from infected macrophages. Microbes Infect. 2010;12(6):497–504.
   PubMed Web of Science ®Google Scholar
• da Cruz Ab, Maia MM, Pereira IDS, et al. Human extracellular vesicles and correlation with two clinical forms of toxoplasmosis. PLoS One. 2020;15(3):e0229602.
   PubMed Web of Science ®Google Scholar
• Bando H, Lee Y, Sakaguchi N, et al. Effector GRA15-dependent suppression of IFN-γ-induced antiparasitic response in human neurons. Front Cell Infect Microbiol. 2019;9:140.
   PubMed Web of Science ®Google Scholar
• Bando H, Sakaguchi N, Lee Y, et al. Effector TgIST targets host IDO1 to antagonize the IFN-γ-induced anti-parasitic response in human cells. Front Immunol. 2018;9:2073.
   PubMed Web of Science ®Google Scholar
• Bhandage AK, Kanatani S, Barragan A. Induced hypermigration of primary cortical microglia implicates GABAergic signaling. Front Cell Infect Microbiol. 2019;9:73.
   PubMed Web of Science ®Google Scholar
• Lau A, Jain MK, Chow JY, et al. Toxoplasmosis encephalitis: a cross-sectional analysis at a U.S. safety-net hospital in the late cART era. J Int Assoc Provid AIDS Care. 2021;20:23259582211043863.
   Google Scholar
• Panel on Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. 2020.
   Google Scholar
• Amare A. Seizure in HIV-infected patients: clinical presentation, cause and treatment outcome in Ethiopia-a retrospective study. BMC Infect Dis. 2021;21(1):790.
   PubMed Web of Science ®Google Scholar
• Kaplan, Jonathan , Benson, Constan , Holmes, King CDC. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents. Vol. 58. 2009. Accessed 2021 4 2021. Recommendations for CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf.
   Google Scholar
• Bondarenko AV, Katsapov DV, Gavrylov AV, et al. Immunodiagnostics of cerebral toxoplasmosis depending on permeability of blood-brain barrier. Wiad Lek. 2020;73(2):285–288.
   PubMedGoogle Scholar
• Gutierrez-Loli R, Ferradas C, Diestra A, et al. Development of a novel protocol based on blood clot to improve the sensitivity of qPCR detection of. Am J Trop Med Hyg. 2019;100(1):83–89.
   PubMed Web of Science ®Google Scholar
• Bokharaei-Salim F, Esteghamati A, Khanaliha K, et al. Evaluation of a PCR assay for diagnosis of toxoplasmosis in serum and peripheral blood mononuclear cell among HIV/AIDS patients. J Parasit Dis. 2020;44(1):159–165.
   PubMedGoogle Scholar
• Wang ZH, Zhang W, Zhang XZ, et al. Development of a real-time recombinase-aided amplification (RT-RAA) molecular diagnosis assay for sensitive and rapid detection of Toxoplasma gondii. Vet Parasitol. 2021;298:109489.
   PubMed Web of Science ®Google Scholar
• Xu M, Gao J, Li S, et al. Metagenomic analysis and identification of emerging pathogens in blood from healthy donors. Sci Rep. 2020;10(1):15809.
   PubMed Web of Science ®Google Scholar
• de Faria Junior GM, Murata FHA, Lorenzi HA, et al. The role of microRNAs in the infection by. Front Cell Infect Microbiol. 2021;11:670548.
   PubMedGoogle Scholar
• Yenilmez E, Çetinkaya RA. Difference in. Turkiye Parazitol Derg. 2019;43(Suppl 1):1–7.
   PubMedGoogle Scholar
• Vargas-Montes M, Cardona N, Moncada DM, et al. Enzyme-Linked Aptamer Assay (ELAA) for detection of. Front Cell Infect Microbiol. 2019;9:386.
   PubMed Web of Science ®Google Scholar
• Konstantinovic N, Guegan H, Stäjner T, et al. Treatment of toxoplasmosis: current options and future perspectives. Food Waterborne Parasitol. 2019;15:e00036.
   PubMedGoogle Scholar
• Foroutan M, Ghaffarifar F, Sharifi Z, et al. Bioinformatics analysis of ROP8 protein to improve vaccine design against Toxoplasma gondii. Infect Genet Evol. 2018;62:193–204.
   PubMed Web of Science ®Google Scholar
• Pellegrino D, Gryschek R, de Oliveira ACP, et al. Efficacy and safety of trimethoprim-sulfamethoxazole in HIV-infected patients with cerebral toxoplasmosis in Brazil: a single-arm open-label clinical trial. Int J STD AIDS. 2019;30(12):1156–1162.
   PubMed Web of Science ®Google Scholar
• Hernandez AV, Thota P, Pellegrino D, et al. A systematic review and meta-analysis of the relative efficacy and safety of treatment regimens for HIV-associated cerebral toxoplasmosis: is trimethoprim-sulfamethoxazole a real option? HIV Med. 2017;18(2):115–124.
   PubMed Web of Science ®Google Scholar
• Li Y, Zeng YM, Lu YQ, et al. A study for precision diagnosing and treatment strategies in difficult-to-treat AIDS cases and HIV-infected patients with highly fatal or highly disabling opportunistic infections. Medicine (Baltimore). 2020;99(20):e20146.
   PubMed Web of Science ®Google Scholar
• Azoulay É, de Castro N, Barbier F. Critically ill patients with HIV: 40 years later. Chest. 2020;157(2):293–309.
   PubMed Web of Science ®Google Scholar
• Schäfer G, Hoffmann C, Arasteh K, et al. Immediate versus deferred antiretroviral therapy in HIV-infected patients presenting with acute AIDS-defining events (toxoplasmosis, Pneumocystis jirovecii-pneumonia): a prospective, randomized, open-label multicenter study (IDEAL-study). AIDS Res Ther. 2019;16(1):34.
   PubMed Web of Science ®Google Scholar
• Zeng YM, Li Y, He XQ, et al. A study for precision diagnosing and treatment strategies in difficult-to-treat AIDS cases and HIV-infected patients with highly fatal or highly disabling opportunistic infections: study protocol for antiretroviral therapy timing in AIDS patients with toxoplasma encephalitis. Medicine (Baltimore). 2020;99(29):e21141.
   PubMed Web of Science ®Google Scholar
• Wang JL, Elsheikha HM, Li TT, et al. Efficacy of antiretroviral compounds against Toxoplasma gondii in vitro. Int J Antimicrob Agents. 2019;54(6):814–819.
   PubMed Web of Science ®Google Scholar
• Nishi L, Santana PL, Evangelista FF, et al. Rosuvastatin reduced brain parasite burden in a chronic toxoplasmosis. Parasitology. 2020;147(3):303–309.
   PubMed Web of Science ®Google Scholar
• Bottari NB, Reichert KP, Fracasso M, et al. Neuroprotective role of resveratrol mediated by purinergic signalling in cerebral cortex of mice infected by Toxoplasma gondii. Parasitol Res. 2020;119(9):2897–2905.
   PubMed Web of Science ®Google Scholar
• Foroutan M, Ghaffarifar F, Sharifi Z, et al. Rhoptry antigens as. Clin Exp Vaccine Res. 2019;8(1):4–26.
   PubMed Web of Science ®Google Scholar
• Warner RC, Chapman RC, Davis BN, et al. Review of DNA vaccine approaches against the parasite toxoplasma gondii. J Parasitol. 2021;107(6):882–903.
   PubMed Web of Science ®Google Scholar
• Mévélec MN, Lakhrif Z, Dimier-Poisson I. Key limitations and new insights into the. Front Cell Infect Microbiol. 2020;10:607198.
   PubMed Web of Science ®Google Scholar
• Dunay IR, Gajurel K, Dhakal R, et al. Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice. Clin Microbiol Rev. 2018;31(4):e00057–17.
   PubMed Web of Science ®Google Scholar
• Connolly MP, Haitsma G, Hernández AV, et al. Systematic review and meta-analysis of secondary prophylaxis for prevention of HIV-related toxoplasmic encephalitis relapse using trimethoprim-sulfamethoxazole. Pathog Glob Health. 2017;111(6):327–331.
   PubMed Web of Science ®Google Scholar
• Connolly MP, Goodwin E, Schey C, et al. Toxoplasmic encephalitis relapse rates with pyrimethamine-based therapy: systematic review and meta-analysis. Pathog Glob Health. 2017;111(1):31–44.
   PubMed Web of Science ®Google Scholar
• Letang E, Rakislova N, Martinez MJ, et al. Minimally invasive tissue sampling: a tool to guide efforts to reduce AIDS-related mortality in resource-limited settings. Clin Infect Dis. 2021;73(Suppl_5):S343–S350.
   PubMedGoogle Scholar
• Li Y, Zeng YM, Liu M, et al. Development of a risk scoring system for prognostication in HIV-related toxoplasma encephalitis. BMC Infect Dis. 2020;20(1):923.
   PubMed Web of Science ®Google Scholar